Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details) - Schedule of stock option activities

v3.22.1
Shareholders' Deficit (Details) - Schedule of stock option activities - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]
Number of Options, Balance Outstanding, Beginning 8,445,698 2,050,000
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.4 $ 0.1
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning
Aggregate Intrinsic Value, Balance Outstanding, Beginning
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Balance Outstanding, Ending 8,445,698 2,050,000
Stock options [Member]
Shareholders' Deficit (Details) - Schedule of stock option activities [Line Items]
Number of Options, Balance Outstanding, Beginning 8,445,698 8,445,698
Number of Options, Exercised
Weighted Average Exercise Price, Exercised
Weighted Average Remaining Contractual Term (Years), Exercised
Aggregate Intrinsic Value, Exercised
Number of Options, Balance Outstanding, Ending 8,445,698 8,445,698
Weighted Average Exercise Price, Balance Outstanding, Ending $ 0.4 $ 0.4
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending 4 years 1 month 6 days 5 years 1 month 6 days
Aggregate Intrinsic Value, Balance Outstanding, Ending $ 0 $ 48,000
Number of Options, Exercisable 8,445,698
Weighted Average Exercise Price, Exercisable $ 0.4
Weighted Average Remaining Contractual Term (Years), Exercisable, 4 years 1 month 6 days
Aggregate Intrinsic Value, Exercisable $ 0